Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16654142 | 0.84 | — | — | |
| SCHEMBL4195444 | 0.80 | — | — | |
| SCHEMBL4641984 | 0.80 | TUBB1 (0.37) | — | |
| SCHEMBL14827136 | 0.79 | CES2 (0.37) | CES2CES1 | |
| SCHEMBL1277219 | 0.79 | ESR1 (0.36) | — | |
| SCHEMBL6677725 | 0.77 | CES2 (0.31) | CES2CES1 | |
| SCHEMBL177573 | 0.74 | CA12 (0.36) | CES2CES1 | |
| SCHEMBL177743 | 0.74 | SOS1 (0.41) | CES2CES1 | |
| SCHEMBL1786644 | 0.74 | — | — | |
| SCHEMBL27486692 | 0.73 | CES2 (0.39) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9909030-B2 | Method for preparing carbon nanotubes graphene modified aqueous polyurethane coatings and adhesives | YANTAI UNIVERSITY (CN) | 2018-03-06 | — | — | US | claimed |
| US-20170114248-A1 | Method For Preparing Carbon Nanotubes Graphene Modified Aqueous Polyurethane Coatings and Adhesives | YANTAI UNIVERSITY | 2017-04-27 | — | — | US | claimed |
| EP-1277755-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT WITH AXIAL ASYMMETRY, PROCESS FOR PRODUCING THE SAME, AND APPLICATION TO ASYMMETRIC SYNTHESIS OF $g(a)-AMINO ACID DERIVATIVE | Nagase & Co., Ltd. (JP) | 2003-01-22 | — | — | EP | claimed |
| US-20260102762-A1 | TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2026-04-16 | — | — | US | disclosed |
| US-12539508-B2 | Tri-(adamantyl) phosphines and applications thereof | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2026-02-03 | — | — | US | disclosed |
| US-20250333383-A1 | N-OXIDE COMPOUNDS AND USE THEREOF | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2025-10-30 | — | — | US | disclosed |
| WO-2025074339-A1 | A PROCESS FOR PREPARATION OF CARBOXAMIDE COMPOUNDS AND INTERMEDIATES THEREOF | UPL LIMITED (IN) | 2025-04-10 | — | — | WO | disclosed |
| EP-4514777-A1 | N-OXIDE COMPOUNDS AND USE THEREOF | SK Biopharmaceuticals Co., Ltd. (KR) | 2025-03-05 | — | — | EP | disclosed |
| US-20240001353-A1 | TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF | UNIV PRINCETON (US) | 2024-01-04 | — | — | US | disclosed |
| EP-4286051-A2 | A METHOD OF CROSS-COUPLING USING A TRANSITION METAL COMPLEX COMPRISING A PAD3 LIGAND | The Trustees of Princeton University (US) | 2023-12-06 | — | — | EP | disclosed |
| WO-2023211195-A1 | N-OXIDE COMPOUNDS AND USE THEREOF | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2023-11-02 | — | — | WO | disclosed |
| US-20060205797-A1 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION | 2006-09-14 | — | — | US | disclosed |
| WO-2006079406-A1 | MESOGENIC COMPOUNDS, LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2006-08-03 | — | — | WO | disclosed |
| WO-2006019768-A1 | HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION (US) | 2006-02-23 | — | — | WO | disclosed |
| WO-2005073204-A1 | SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS | ELI LILLY AND COMPANY (US) | 2005-08-11 | — | — | WO | disclosed |
| EP-1277755-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT WITH AXIAL ASYMMETRY, PROCESS FOR PRODUCING THE SAME, AND APPLICATION TO ASYMMETRIC SYNTHESIS OF $g(a)-AMINO ACID DERIVATIVE | Nagase & Co., Ltd. (JP) | 2003-01-22 | — | — | EP | disclosed |
| US-6441231-B1 | SPIRO QUARTERNARY AMMONIUM SALT COMPOUNDS, USED AS PHASE TRANSFER CATALYST FOR STEREOSELECTIVE ALKYLATION | NAGASE & CO., LTD. (JP) | 2002-08-27 | — | — | US | disclosed |
| US-20020103374-A1 | OPTICALLY ACTIVE QUARTERNARY AMMONIUM SALT WITH AXIAL CHIRALITY, METHOD FOR PRODUCING THEREOF, AND APPLICATION THEREOF FOR ASYMMETRIC SYNTHESIS OF ALPHA-AMINO ACID | NAGASE & CO., LTD (JP) | 2002-08-01 | — | — | US | disclosed |
| US-20020065414-A1 | Optically active quarternary ammonium salt with axial chirality, method for producing thereof, and aplication thereof for asymmetric synthesis of alpha-amino acid | NAGASE & CO., LTD. (JP) | 2002-05-30 | — | — | US | disclosed |
| US-6340753-B1 | CATIONIC QUATERNARY AMMONIUM COMPOUNDS DEHYDROHALOGENATION OF COMPOUNDS TO FORM AMINES | NAGASE & CO., LTD. (JP) | 2002-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333383-A1 | N-OXIDE COMPOUNDS AND USE THEREOF | SCNN1B, SCN1B, SCN2B | CES2 1584/4885CES1 3595/4885 |
| US-20020065414-A1 | Optically active quarternary ammonium salt with axial chirality, method for producing thereof, and aplication thereof for asymmetric synthesis of alpha-amino acid | AADAT, AASDHPPT, BCAT1 | CES2 3976/4885CES1 1963/4885 |
| US-20060205797-A1 | Compounds for the treatment of inflammatory disorders | TNF, MMP12, MMP8 | CES2 531/4885CES1 180/4885 |
| US-12539508-B2 | Tri-(adamantyl) phosphines and applications thereof | OTC, AOC3, ICOSLG | CES2 426/4885CES1 941/4885 |
| US-20020103374-A1 | OPTICALLY ACTIVE QUARTERNARY AMMONIUM SALT WITH AXIAL CHIRALITY, METHOD FOR PRODUCING THEREOF, AND APPLICATION THEREOF FOR ASYMMETRIC SYNTHESIS OF ALPHA-AMINO ACID | AADAT, BCAT1, BCAT2 | CES2 3731/4885CES1 1913/4885 |
| US-20260102762-A1 | TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF | PTMS, TEC, CD2 | CES2 1111/4885CES1 2044/4885 |
| US-20240001353-A1 | TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF | PADI3, ADA, ENTPD3 | CES2 563/4885CES1 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.